Benjamin Nguyen, MD
Physical Medicine & Rehabilitation · Richardson, TXNPI 1609945690
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $431 and has fallen 59.6% since, to $174 in 2025.
Across 35 payments — averaging $37.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$252
- MDD US Operations, LLC$231
- Medtronic$194
- Merz Pharmaceuticals, LLC$169
- Saol Therapeutics Inc.$131
- Ipsen Biopharmaceuticals, Inc$99
- plus $247 from 9 others
What the payments were for
- Food & beverage$1,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 6 | $252 |
| MDD US Operations, LLC | 8 | $231 |
| Medtronic(2 entities) | 3 | $194 |
| Merz Pharmaceuticals, LLC | 2 | $169 |
| Saol Therapeutics Inc. | 3 | $131 |
| Ipsen Biopharmaceuticals, Inc | 2 | $99 |
| Greenwich Biosciences, Inc. | 1 | $57 |
| Merz North America, Inc. | 2 | $39 |
| AstraZeneca | 1 | $34 |
| Fresenius Kabi USA, LLC | 2 | $33 |
| CSL Behring | 1 | $22 |
| GE HealthCare | 1 | $18 |
| Tersera Therapeutics LLC | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Piramal Critical Care | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$155
- SYNCHROMEDII$151
- MYOBLOC$127
- BOTOX$125
How this compares
$1,324 in reported general payments places this provider in the 80th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,971 |
| Gabapentin | 65 | $1,635 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $1,579 |
| Baclofen | 58 | $1,274 |
| Lidocaine | 18 | $971 |
| Methylphenidate Hcl | 42 | $899 |
| Duloxetine Hcl | 14 | $360 |
| Tizanidine Hcl | 29 | $227 |
| Atorvastatin Calcium | 23 | $221 |
| Cyclobenzaprine Hcl | 12 | $188 |
| Trazodone Hcl | 31 | $165 |
| Rosuvastatin Calcium | 13 | $119 |
| Meloxicam | 12 | $104 |
| Pantoprazole Sodium | 12 | $93 |
| Amlodipine Besylate | 15 | $87 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Richardson
- Andrew WilkinsRichardson$5K
- Gerard FranciscoHouston$364K
- Jose UrquidezAustin$332K
- Gireesh ShardaDallas$172K
- Suzanne ManziHouston$143K
- Cindy IvanhoeHouston$111K
- Chad McNeilTyler$64K
- Sheng LiHouston$44K
- Mary RussellShenandoah$37K
- Randall WolcottLubbock$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.